Tag: SKYLIGHT Trials

Fezolinetant Basics for Patients is available at this link: Fezolinetant Basics for Patients. What is fezolinetant (VeozahTM) and its mechanism of action? Fezolinetant is a neurokinin-3 receptor antagonist.1 The FDA approved it for treating menopausal vasomotor symptoms (aka hot flashes). The antagonism blocks neurokinin B from acting in the brain’s thermoregulatory center.1 This decreases hot…